KURA ONCOLOGY, INC. (KURA)

SEC filing

KURA ONCOLOGY, INC.

KURA · CIK 1422143

4 · Sep 10, 2026 · Chief Financial Officer Fulk Jennifer was granted 450K Option to purchase common stock

Chief Financial Officer Fulk Jennifer was granted 450K Option to purchase common stock

Could not load the primary document from EDGAR (SEC rate limit, timeout, or temporary upstream error). Refresh in a minute, or use View on SEC.gov.